Agneta Wennerholm

Agneta Wennerholm

UNVERIFIED PROFILE

Are you Agneta Wennerholm?   Register this Author

Register author
Agneta Wennerholm

Agneta Wennerholm

Publications by authors named "Agneta Wennerholm"

Are you Agneta Wennerholm?   Register this Author

6Publications

93Reads

34Profile Views

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population.

Pharmacogenet Genomics 2006 Sep;16(9):637-45

Department of Clinical Toxicology, Central Laboratories & Blood Bank, King Fahad Medical City, Riyadh 11525, Kingdom of Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.fpc.0000230411.89973.1bDOI Listing
September 2006

Amodiaquine, its desethylated metabolite, or both, inhibit the metabolism of debrisoquine (CYP2D6) and losartan (CYP2C9) in vivo.

Eur J Clin Pharmacol 2006 Jul 17;62(7):539-46. Epub 2006 Jun 17.

Division of Clinical Pharmacology C1:68, Karolinska University Hospital - Huddinge, SE-141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-006-0121-3DOI Listing
July 2006

Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.

Eur J Clin Pharmacol 2005 Apr 2;61(2):113-8. Epub 2005 Apr 2.

Division of Clinical Pharmacology C1:68, Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-004-0861-xDOI Listing
April 2005

Simultaneous quantification of alprazolam, 4- and alpha-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry.

J Chromatogr B Analyt Technol Biomed Life Sci 2005 Jan;814(1):127-31

Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, S-141 86 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2004.10.012DOI Listing
January 2005

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Eur J Clin Pharmacol 2002 Nov 1;58(8):555-8. Epub 2002 Nov 1.

Department of Medical Laboratory Sciences and Technology, Division of Clinical Pharmacology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sewden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-002-0518-6DOI Listing
November 2002

The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.

Clin Pharmacol Ther 2002 Jan;71(1):77-88

Division of Clinical Pharmacology, Department of Medical Laboratory Sciences and Technology, Karolinska Institutet at Huddinge University Hospital, Stockholm.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/mcp.2002.120239DOI Listing
January 2002